| Tap a line for its trend | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 12.59× | 12.27× | 14.18× | 16.80× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.62× | 0.77× | 0.87× | 0.78× | ||
| 1.13× | 0.97× | 1.13× | 1.19× | ||
| 0.82× | 0.71× | 0.79× | 0.77× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | |
|---|---|---|---|---|---|
| Receivable Days (DSO) | 16.80 | 14.18 | 12.27 | 12.59 | |
| Asset Turnover | 0.78 | 0.87 | 0.77 | 0.62 | |
| Cash Conversion (CFO/Net Income) | 1.19 | 1.13 | 0.97 | 1.13 | |
| CFO/EBITDA | 0.77 | 0.79 | 0.71 | 0.82 |